World TB Day! Overview of Events, News and Messages

Click here to get more info.

Saturday, March 24, is officially World TB Day but there has been a stream of activities, publications, news and messages to let the world not forget about this major infectious disease killer that claims millions of lives each year.


  • On March 7 and 13, the CORE Group sponsored two webinars on pediatric TB which fit well within the focus on childhood TB for this World TB Day. You can access both webinars at
  • March 16, TB Alliance sponsored “U.S. Advocates Workshop on TB Research and Development” at the Gates Foundation Office in Washington, D.C. The objectives of the meeting were to develop messages for TB research and identify opportunities to communicate them, and to align advocacy strategies to enable R&D issues to be incorporated into ongoing TB advocacy. There were representatives from Aeras, American Thoracic Society, AVAC, Global Health Council, Research!America, RESULTS, Treatment Action Group, and others. For more information contact Heather Ignatius,
  • March 19, the Critical Path to TB Drug Regiments (CPTR) sponsored the event “Cure All: A briefing on the most promising TB drug research.” Click here to read a summary of the event on the blog. Video, photos, and slide presentations of the event can be found at
  • March 21, The TB Elimination Caucus in the House of Representative launched with over 80 people in attendance including 35 congressional staffers. The caucus is sponsored by Congressman Elliott Engel (NY), Congressman Don Young (Alaska), and Congressman Gene Greene (Texas). The three Congressmen spoke of strong interest in continued U.S. funding for TB and ideas of gaining greater support for TB in the U.S. Congress. Click here for additional coverage.

Go to to find out about other upcoming events in TB.


Special Announcements

World TB Day Messages

Additional Coverage

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...